Mereo BioPharma Group (MREO) Balance Sheet Annual - Discounting Cash Flows
Mereo BioPharma Group plc
MREO (NASDAQ)

* (except for per share items) of USD
Period Ending: 2023
12-31
2022
12-31
2021
12-31
2020
12-31
2019
12-31
2018
12-31
2017
12-31
2016
12-31
2015
12-31
Report Filing: 2024-03-27 2023-03-28 2022-03-31 2021-03-31 2020-06-15 2019-04-29 2017-12-31 2016-12-31 2015-12-31
Total Current Assets 63.8 62.1 99.3 29.7 30.4 34.5 63.2 60.8 81.3
Cash and Short Term Investments 57.4 56.3 94.3 23.5 16.3 27.5 52.5 53.6 79.7
Cash & Equivalents 57.4 56.3 94.3 23.5 16.3 25.0 50.0 53.6 79.7
Short Term Investments 0.00 51.1 0.57 0.55 0.54 2.50 2.50 0.00 0.00
Receivables 3.73 2.75 1.42 1.02 0.00 0.00 0.00 0.00 0.00
Inventory 0.00 -2.67 -1.82 -4.64 -12.0 -0.29 -2.50 -53.9 0.00
Other Current Assets 2.61 5.72 5.43 9.88 26.1 7.25 13.1 61.1 1.60
Total Assets 66.5 88.1 126 62.9 86.4 67.3 96.3 86.8 107
Total Non-Current Assets 2.74 25.9 27.1 33.2 56.0 32.8 33.2 26.0 26.0
Property, Plant and Equipment 1.65 1.83 2.53 1.57 11.6 0.15 0.15 0.17 0.20
Goodwill and Intangible Assets 1.09 24.1 24.6 31.6 44.5 32.6 33.0 25.8 25.8
Goodwill 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Intangible Assets 1.09 24.1 24.6 31.6 44.5 32.6 33.0 25.8 25.8
Long Term Investments 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Deferred Tax Assets 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Other Long Term Assets 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Total Current Liabilities 9.49 24.7 12.5 8.56 29.9 16.2 9.62 3.21 2.82
Accounts Payable 2.35 3.49 2.28 2.94 5.88 5.57 2.64 1.23 1.08
Notes Payable/Short Term Debt 0.65 11.6 0.62 0.64 17.7 6.84 1.94 0.00 0.00
Tax Payables 0.66 0.17 1.71 0.15 0.18 0.16 0.14 0.11 0.00
Deferred Revenue 0.00 0.00 8.36 0.00 5.45 -0.18 -0.16 0.00 0.00
Other Current Liabilities 5.83 9.43 -0.44 4.85 0.64 3.78 5.06 1.87 1.74
Total Liabilities 16.0 26.2 38.4 77.9 46.2 34.5 33.9 7.51 5.76
Total Non-Current Liabilities 6.48 1.53 25.9 69.4 16.3 18.3 24.2 4.30 2.94
Total Long Term Debt 5.30 1.48 1.75 17.3 19.3 14.6 18.8 3.13 2.80
Deferred Tax Liabilities Non-Current 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Deferred Revenue Non-Current 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Capital Lease Obligations 1.56 2.04 2.38 1.79 14.8 0.00 0.00 0.00 0.00
Other Long Term Liabilities -0.38 -1.99 21.7 50.3 -17.8 3.68 5.42 1.17 0.14
Total Equity 50.5 61.9 88.0 -15.0 40.3 32.8 62.5 79.3 102
Non-Controlling Interest 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Total Stockholders' Equity 50.5 61.9 88.0 -15.0 40.3 32.8 62.5 79.3 102
Retained Earnings -420 -331 -297 -310 -146 -111 -79.3 -33.6 -12.2
Accumulated Other Earnings -17.5 138 137 133 47.3 25.6 23.4 12.7 0.00
Common Stock 2.78 1.88 1.76 1.02 0.29 0.21 0.21 0.19 0.06
Preferred Stock 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Additional Paid in Capital 485 488 383 295 199 174 168 126 15.8
Total Liabilities & Total Equity 66.5 88.1 126 62.9 86.4 67.3 96.3 86.8 107
Total Liabilities & Shareholders' Equity 66.5 88.1 126 62.9 86.4 67.3 96.3 86.8 107
Total Investments 0.00 51.1 0.57 0.55 0.54 2.50 2.50 0.00 0.00
Total Debt 5.95 12.8 16.8 17.9 32.4 21.5 20.8 3.13 2.80
Net Debt -51.5 -43.6 -77.5 -5.53 16.1 -3.56 -29.3 -50.5 -76.9
discounting cash flows home logo

Discounting Cash Flows

Are you finding our services helpful? Review us on trustpilot logo Trustpilot
Have a question? Contact us